65,437 trials
Healthy
Primary: Cmax — 812.477; 945.456 pg/mL — p=0.0328
Nephrolithiasis
Primary: Protocol Feasibility — 14; 10 Participants
Respiratory Failure
Primary: Ventilator-free Days (VFDs) to Study Day 28 — 20; 21; 21 number of days
Hair Removal
Primary: Reduction in Hair Count in the Treated Area — 13.1; 10.7; 18.7 percentage of hair reduction
Systemic Lupus Erythematosus
Primary: Change From Baseline to Month 6 in the Modified Systemic Lupus Erythematosus Activity Index 2000 (mSLEDAI-2K) Score — -3.2; -3.41; -2.84; -4.04 score on a scale — p=0.4749
Acute Myeloid Leukemia
Primary: Number of Patients With 2-year Relapse Risk — 10 Participants
Alzheimer's Disease
Primary: Period A: Annualized Rate of Change in the Autosomal-Dominant Alzheimer's Disease (API ADAD) Composite Cognitive Test Total Score — -1.10; -1.42 points on scale per year…
Chronic Cough
Primary: Percent Change From Baseline in Average Daily Cough-induced Stress Urinary Incontinence (SUI) Episodes at Week 12 — -41.09; -52.78 Percent Change — p=0.004
HIV Prevention
Primary: Completion of Exit Interview — 28 Participants
Hypertension
Primary: Change in Mean Systolic Blood Pressure — -15.65; -10.87 mm Hg — p=0.114
Prostate Cancer
Primary: Change From Baseline in Body Composition (Lean Body Mass) — 54.93; 57.58; -1.27; -0.60 Kilogram — p=0.1497
Diabetic Foot Ulcer
Primary: Proportion of Subjects Achieving Target Ulcer Closure Within 12-week Treatment Phase, as Assessed by Blinded Investigator — 41; 30; 10 Participants — p=0.0276
Cancer
Primary: The Number of Patients Who Enrolled Completed the Study. — 23; 10 Participants
Scabies
Primary: Mortality Rate for Adult Scabies Mites — 2; 6; 8; 14 Adult mites
Elder Abuse · Elder Mistreatment
Primary: Participation — 102 Participants